Quanterix (Lexington, Massachusetts), a developer of high definition diagnostics, reported that JAMA Neurology has published a ground-breaking study in which its Simoa (single molecule array) technology was used to directly measure the brain protein Tau in the blood of athletes who had sustained mild traumatic brain injuries or concussions. These measurements have never before been possible in blood, the company noted. Read More
